The Impact of Deep Local Lung Hyperthermia on COVID-19 Cancer Patients
- PMID: 39717255
- PMCID: PMC11665143
- DOI: 10.4103/abr.abr_75_23
The Impact of Deep Local Lung Hyperthermia on COVID-19 Cancer Patients
Abstract
Background: The goal of this study was to assess the impact of deep local hyperthermia on oxygen (O2) saturation and infected volumes of lungs on coronavirus disease 2019 (COVID-19) cancer patients.
Materials and methods: Fifty patients who suffered from COVID-19 (according to their computed tomography (CT) images and laboratory findings) were included in this study. The mentioned patients were divided into two groups (I and II) with thirty-five participants. The infected volumes and COVID-19 infectious locations were diagnosed using their CT images, and deep local hyperthermia was performed for group II. After three consequent days, the SPO2, D-dimer, and infected volumes of lung parenchyma of both groups were compared to each other.
Results: For group II, the mean ± SD (standard deviation) of O2 pressure saturation (SPO2) before/after hyperthermia was 85 ± 0.0/91.3 ± 0.5, respectively, while for group I, the mean ± SD of SPO2 before/after 3 days was 85 ± 0.0/88 ± 0.2, respectively. For infected volumes of lungs before/after hyperthermia in group II, the mean ± SD was 31.36 ± 3.13/4 ± 1.53, respectively. Nonetheless, the infected volumes of lungs for group I were 34.21 ± 3.41/10 ± 2.12 before/after three days. For group II, the amount of D-dimer before/after hyperthermia was 3200 ± 106/510 ± 121, respectively. However, for group I, it was 3100/740 before/after the consequent three days, respectively.
Conclusion: Deep local lung hyperthermia for COVID-19 cancer patients is suggested, as a result of its positive impacts on SPO2 improvement and also D-dimer serum level, C-reactive protein, and Lactate dehydrogenaze reduction for the mentioned patients.
Keywords: COVID-19; Cancer; D-dimer; SPO2; hyperthermia; lung.
Copyright: © 2024 Advanced Biomedical Research.
Conflict of interest statement
There are no conflicts of interest.
Figures
Similar articles
-
Letter to the editor: efficacy of different methods of combination regimen administrations including dexamethasone, intravenous immunoglobulin, and interferon-beta to treat critically ill COVID-19 patients: a structured summary of a study protocol for a randomized controlled trial.Trials. 2020 Jun 19;21(1):549. doi: 10.1186/s13063-020-04499-5. Trials. 2020. PMID: 32560745 Free PMC article.
-
Clinical and laboratory data, radiological structured report findings and quantitative evaluation of lung involvement on baseline chest CT in COVID-19 patients to predict prognosis.Radiol Med. 2021 Jan;126(1):29-39. doi: 10.1007/s11547-020-01293-w. Epub 2020 Oct 12. Radiol Med. 2021. PMID: 33047295 Free PMC article.
-
[Evaluation of the Effects of Tocilizumab Use on Oxygen Parameters, Inflammatory Markers and Survival in Patients Diagnosed with COVID-19 in Intensive Care Unit].Mikrobiyol Bul. 2023 Jan;57(1):97-107. doi: 10.5578/mb.20239908. Mikrobiyol Bul. 2023. PMID: 36636849 Turkish.
-
Does follow-up D-dimer level help in predicting oxygenation status, ventilatory support requirement, lung fibrosis, and thromboembolic events in coronavirus disease 2019 pneumonia? A prospective observational study in a tertiary care setting in India.Ann Afr Med. 2023 Jul-Sep;22(3):286-292. doi: 10.4103/aam.aam_47_22. Ann Afr Med. 2023. PMID: 37417015 Free PMC article.
-
[Clinical study of awake prone positioning treatment in patients with common coronavirus disease 2019 caused by Omicron variant].Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2022 Jun;34(6):576-580. doi: 10.3760/cma.j.cn121430-20220418-00384. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2022. PMID: 35924510 Chinese.
References
-
- van der Zee J, Gonzalez Gonzalez D, van Rhoon GC, van Dijk JD, van Putten WL, Hart AA. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumors: A prospective, randomized, multicenter trial. Dutch Deep Hyperthermia Group. Lancet. 2000;355:1119–25. - PubMed
-
- Siegel R, DeSantis C, Virgo K, Stein K, Mariotto A, Smith T, et al. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin. 2012;62:220–41. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials